142 related articles for article (PubMed ID: 29416926)
1. ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.
Xiao J; Shi Q; Li W; Mu X; Peng J; Li M; Chen M; Huang H; Wang C; Gao K; Fan J
Am J Cancer Res; 2018; 8(1):132-143. PubMed ID: 29416926
[TBL] [Abstract][Full Text] [Related]
2. Α-arrestin 1 (ARRDC1) and β-arrestins cooperate to mediate Notch degradation in mammals.
Puca L; Chastagner P; Meas-Yedid V; Israël A; Brou C
J Cell Sci; 2013 Oct; 126(Pt 19):4457-68. PubMed ID: 23886940
[TBL] [Abstract][Full Text] [Related]
3. Divergent regulation of α-arrestin ARRDC3 function by ubiquitination.
Wedegaertner H; Bosompra O; Kufareva I; Trejo J
Mol Biol Cell; 2023 Aug; 34(9):ar93. PubMed ID: 37223976
[TBL] [Abstract][Full Text] [Related]
4. ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation.
Chen M; Yin B; Liu Y; Li M; Shen S; Wu J; Li W; Fan J
Cell Cycle; 2024 Jan; 23(1):56-69. PubMed ID: 38389126
[TBL] [Abstract][Full Text] [Related]
5. α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis.
Arakaki AKS; Pan WA; Wedegaertner H; Roca-Mercado I; Chinn L; Gujral TS; Trejo J
J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33722977
[TBL] [Abstract][Full Text] [Related]
6. The α-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting.
Dores MR; Lin H; J Grimsey N; Mendez F; Trejo J
Mol Biol Cell; 2015 Dec; 26(25):4660-73. PubMed ID: 26490116
[TBL] [Abstract][Full Text] [Related]
7. The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer.
Wedegaertner H; Pan WA; Gonzalez CC; Gonzalez DJ; Trejo J
Antioxid Redox Signal; 2022 May; 36(13-15):1066-1079. PubMed ID: 34465145
[No Abstract] [Full Text] [Related]
8. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP.
Shen X; Sun X; Sun B; Li T; Wu G; Li Y; Chen L; Liu Q; Cui M; Zhou Z
FEBS Lett; 2018 Feb; 592(4):599-609. PubMed ID: 29364502
[TBL] [Abstract][Full Text] [Related]
9. High TEAD4 Expression is Associated With Aggressive Clear Cell Renal Cell Carcinoma, Regardless of YAP1 Expression.
Park MA; Lee YH; Gu MJ
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):649-656. PubMed ID: 37779294
[TBL] [Abstract][Full Text] [Related]
10. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
[TBL] [Abstract][Full Text] [Related]
11. Arrestin-Domain Containing Protein 1 (Arrdc1) Regulates the Protein Cargo and Release of Extracellular Vesicles.
Anand S; Foot N; Ang CS; Gembus KM; Keerthikumar S; Adda CG; Mathivanan S; Kumar S
Proteomics; 2018 Sep; 18(17):e1800266. PubMed ID: 30035390
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-Interacting Protein in Cancer and Diabetes.
Masutani H
Antioxid Redox Signal; 2022 May; 36(13-15):1001-1022. PubMed ID: 34384271
[No Abstract] [Full Text] [Related]
13. Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b.
Soung YH; Chung H; Yan C; Ju J; Chung J
Cells; 2019 Jul; 8(7):. PubMed ID: 31295851
[TBL] [Abstract][Full Text] [Related]
14. ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.
Draheim KM; Chen HB; Tao Q; Moore N; Roche M; Lyle S
Oncogene; 2010 Sep; 29(36):5032-47. PubMed ID: 20603614
[TBL] [Abstract][Full Text] [Related]
15. NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
Front Oncol; 2020; 10():591698. PubMed ID: 33489890
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin ligase STUB1 suppresses tumorigenesis of renal cell carcinomas through regulating YTHDF1 stability.
Ma S; Sun Y; Gao G; Zeng J; Chen K; Zhao Z
Carcinogenesis; 2024 May; ():. PubMed ID: 38795009
[TBL] [Abstract][Full Text] [Related]
19. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
